Hiroyuki Inagawa

Hiroyuki Inagawa

Auto-generated profile, based on publicly available information

Hiroyuki Inagawa

Faculty of Medicine, Kagawa University, Miki-cho, Kita-gun, Kagawa, Japan; Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Akiba-ku, Niigata, Japan; Control of Innate Immunity TRA, Bio-Lab, Kagawa, Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2008 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
KHKeiji Hirota
Keiji Hirota
KTKeishiro Tomoda
Keishiro Tomoda
HIHiroyuki Inagawa
Hiroyuki Inagawa
CKChie Kohchi
Chie Kohchi
GSGen-Ichiro Soma
Gen-Ichiro Soma
HTHiroshi Terada
Hiroshi Terada

1 January 2008 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
GSGen-Ichiro Soma
Gen-Ichiro Soma
HIHiroyuki Inagawa
Hiroyuki Inagawa
TNTakashi Nishizawa
Takashi Nishizawa
NYNoriko Yoshioka
Noriko Yoshioka
YTYoshie Taniguchi
Yoshie Taniguchi
CKChie Kohchi
Chie Kohchi
Gram-negative bacteria contain lipopolysaccharides (LPS), which are generally considered to be an endotoxin that has negative impacts on humans. There have been very few therapeutic drugs developed that contain LPS. Recently, it has been reported that hygienic improvements have decreased exposure to LPS, and this is correlated with an increase in allergenic diseases. Lack of exposure to LPS may adversely affect the immune balance in the body. LPS is the substance that has the greatest known effect in activating macrophages which play a central role in the innate immune system. We have hypothesized the existence of a network formed by tissue macrophages and have termed this putative communications network a macrophage network. We studied certain edible Gram-negative bacteria that have a long history of use in traditional food production, in order to discover ways to improve and/or maintain health. In 1991 we discovered that the LPS of Pantoea agglomerans (named IP-PA1 by us) was a macrophage-activating substance that could be obtained from water extracts of wheat flour. LPS is also part of the make-up of cells of other well known Gram-negative bacteria used in food processing such as Acetobacter (vinegar, yogurt) and Xanthomonas (xanthan gum). This demonstrates that humans have a long history of consuming Gram-negative bacteria and LPS. In this manuscript, we discuss the potential for utilizing IP-PA1 and other LPS from edible Gram-negative bacteria. Forms of LPS can be used in various fields, such as in health food, to prevent and improve metabolic syndromes and allergies. They can also be used in feedstuffs for stockbreeding and in aquatic culture as defenses against infection where they can replace antibiotics or chemical substances.

10 August 2005 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
KNKazue Nakata
Kazue Nakata
HIHiroyuki Inagawa
Hiroyuki Inagawa
TNTakashi Nishizawa
Takashi Nishizawa
THTeruko Honda
Teruko Honda
CKChie Kohchi
Chie Kohchi
GSGen-Ichiro Soma
Gen-Ichiro Soma

1 September 2017 in Carbohydrate Research
Verified
Journal Article
Closed access
MHMasahito Hashimoto
Masahito Hashimoto
RSRune Satou
Rune Satou
MOMami Ozono
Mami Ozono
HIHiroyuki Inagawa
Hiroyuki Inagawa
GSGen-Ichiro Soma
Gen-Ichiro Soma

1 January 2014 in Journal of the Japanese Society of Intensive Care Medicine
Verified
Journal Article
Open access
YOYasusei Okada
Yasusei Okada
HIHiroshi Inagawa
Hiroshi Inagawa
NKNaoki Kojima
Naoki Kojima
KYKazumasa Yamaguchi
Kazumasa Yamaguchi
NSNobuo Sasaki
Nobuo Sasaki